Pharma Pulse 2/13/25: PwC Report Identifies Top Trends in Pharma, Counseling About Cannabis Use is Crucial & more

PwC Report Identifies Top Trends in Pharma

PwC report identifies transformative trends impacting the pharma market this year and into the future.

As Use Becomes More Widespread, Counseling About Cannabis Use Is Crucial

The trend toward higher-potency marijuana could pose additional, unknown risks.

DOGE Cuts Pose Risk to Largest Government Contractors

The Trump administration’s moves to trim government spending pose a short-term “understated risk” for companies all across the corporate credit market, according to a Barclays Plc analysis.

SmithRx Unveils 2024 Growth Momentum, Reducing Pharmacy Benefit Costs by an Average of 30%

SmithRx published its newest report, “SmithRx: Milestones and Momentum in 2024,” which unveiled the company’s significant growth, cost savings, customer satisfaction, and market traction from 2024. The momentum SmithRx achieved over the past year is a direct result of the company’s commitment to challenging legacy models, driving innovation, and delivering value beyond dollars and cents – reflecting how SmithRx is building a new pharmacy benefits system that works for employers and employees alike.

Nicholas Saraceno on LinkedIn

Always proud of the work that we produce at Pharmaceutical Commerce Magazine, and this month's February installment is no different! Certainly a labor of love if you will.

There's lots of buzz around the brand for a multitude of reasons - whether that be due to our two new columnists or the thought-provoking content we put out, including my sit-down with some of the industry's top third-party logistics providers. I recommend checking all of it out at the link below.

https://lnkd.in/grvK5Xwb

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs